(Adnkronos)
To the green light for monoclonal antibodies in Italy. The technical scientific commission of AIFA, still meeting, should give the ok to the use of two antibodies. There should be some limitations to their use on patients in line with those expected in Canada. This is what theAdnkronos Health from qualified sources.
–
